ConductScience.org, home

Paper41268321

Pharmacokinetics and pharmacological activities of protopanaxatriol.

Hu Y and 2 others. J Ginseng Res, 2025. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics and pharmacological activities of protopanaxatriol. Papers, record 41268321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41268321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics and pharmacological activities of protopanaxatriol.
PubMed
Journal
J Ginseng Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
2.02, provisional
iCite
Revised in PubMed
2025-11-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu YYeye
2Cho JYJae Youl
3Kim MYMi-Yeon

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References90

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140843020Protopanaxatriol, a ginsenoside metabolite, induces apoptosis in colorectal cancer cells and arrests their cell cycle by targeting AKT.J Ginseng Res2025https://conductscience.org/library/papers/40843020PubMed
236644389Roles of ginsenosides in sepsis.J Ginseng Res2023https://conductscience.org/library/papers/36644389PubMed
336382689Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials.Phytother Res2023https://conductscience.org/library/papers/36382689PubMed
427818927Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC-MS/MS: Rg1 excretion in rat bile, urine and feces.Acta Pharm Sin B2016https://conductscience.org/library/papers/27818927PubMed
534749235Ginsenoside (20S)-protopanaxatriol induces non-protective autophagy and apoptosis by inhibiting Akt/mTOR signaling pathway in triple-negative breast cancer cells.Biochem Biophys Res Commun2021https://conductscience.org/library/papers/34749235PubMed
622563256Effects of protopanaxatriol-ginsenoside metabolites on rat N-methyl-d-aspartic Acid receptor-mediated ion currents.Korean J Physiol Pharmacol2012https://conductscience.org/library/papers/22563256PubMed
723391424Different pharmacokinetics of the two structurally similar dammarane sapogenins, protopanaxatriol and protopanaxadiol, in rats.Fitoterapia2013https://conductscience.org/library/papers/23391424PubMed
815036657
20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide.
Cancer Lett2004https://conductscience.org/library/papers/15036657PubMed
939036733Effects of Panax species and their bioactive components on allergic airway diseases.J Ginseng Res2024https://conductscience.org/library/papers/39036733PubMed
1034271119Inhibitory activities of 20(R, S)-protopanaxatriol against epidermal growth factor receptor tyrosine kinase.Food Chem Toxicol2021https://conductscience.org/library/papers/34271119PubMed
1134975775Solid-State Fermentation With Aspergillus cristatus Enhances the Protopanaxadiol- and Protopanaxatriol-Associated Skin Anti-aging Activity of Panax notoginseng.Front Microbiol2021https://conductscience.org/library/papers/34975775PubMed
122610949920(S)-protopanaxatriol inhibits liver X receptor α-mediated expression of lipogenic genes in hepatocytes.J Pharmacol Sci2015https://conductscience.org/library/papers/26109499PubMed
1340118196Traditional Herbal Medicine Pithecellobium clypearia (Jack) Benth: Research progress in chemical constituents and pharmacological activities.J Ethnopharmacol2025https://conductscience.org/library/papers/40118196PubMed
1436292949Integrated Metabolomics and Network Pharmacology to Decipher the Latent Mechanisms of Protopanaxatriol against Acetic Acid-Induced Gastric Ulcer.Int J Mol Sci2022https://conductscience.org/library/papers/36292949PubMed
1531926987Ginsenoside metabolite 20(S)-protopanaxatriol from Panax ginseng attenuates inflammation-mediated NLRP3 inflammasome activation.J Ethnopharmacol2020https://conductscience.org/library/papers/31926987PubMed
1638465212Sustainable production of natural products using synthetic biology: Ginsenosides.J Ginseng Res2024https://conductscience.org/library/papers/38465212PubMed
173703748820(S)-protopanaxatriol inhibited D-galactose-induced brain aging in mice via promoting mitochondrial autophagy flow.Phytother Res2023https://conductscience.org/library/papers/37037488PubMed
1838195040Rare ginsenosides: A unique perspective of ginseng research.J Adv Res2024https://conductscience.org/library/papers/38195040PubMed
1936644384Microbiota, co-metabolites, and network pharmacology reveal the alteration of the ginsenoside fraction on inflammatory bowel disease.J Ginseng Res2023https://conductscience.org/library/papers/36644384PubMed
2030269219Protective effects of protopanaxatriol on acute liver injury induced by concanavalin A.Naunyn Schmiedebergs Arch Pharmacol2019https://conductscience.org/library/papers/30269219PubMed

See all 90 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42719414Emerging and underexplored ginsenosides in cancer therapy (2020-2025): Beyond cytotoxic mechanisms.J Ginseng Res2026https://conductscience.org/library/papers/42719414PubMed
42719322The roles of ginseng and ginsenosides for immune regulation: Relation to immunometabolic responses.J Ginseng Res2026https://conductscience.org/library/papers/42719322PubMed
42395029Panax ginseng as a proteome-metabolome medicinal ecosystem: Reframing pharmacology beyond a strictly saponin-centric paradigm.J Ginseng Res2026https://conductscience.org/library/papers/42395029PubMed
42395025Ginsenosides from Panax ginseng: Their mechanisms, microbiome determinants, and translational strategies in therapeutic activity against cancer.J Ginseng Res2026https://conductscience.org/library/papers/42395025PubMed
42395013Ginsenoside Rb2 modulates the skin barrier by targeting Src to regulate PI3K/Akt signaling in HaCaT cells.J Ginseng Res2026https://conductscience.org/library/papers/42395013PubMed
41788581Cellular and molecular regulation of skin by ginseng and its bioactive Constituents: A review of studies from 2021 to 2025.J Ginseng Res2026https://conductscience.org/library/papers/41788581PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41268321

GET https://conductscience.org/api/papers/v1/41268321/references?page=2